Worth reading
67In focus
Scored from 2 of 5 sectionsDirection
Neutral
Direction inferred from the company’s description.Scale
830000
SharesWording
Definitive
How definitive the wording is.Details of issuance or disposal
Exercise of stock acquisition rights with an exercise price adjustment clause
発行・処分する株式数
830,000 new shares; 0 treasury shares transferred
発行済株式総数
Equivalent to 10.00% of the 8,300,000 issued shares (830,000 shares)
The dilution rate shows what proportion the newly issued shares represent of the existing shares. The higher the proportion, the more the value and voting rights per share are diluted.
Terms of the stock acquisition rights
Exercise price
¥394 (26 March 2026). Details of the adjustment clause and the adjustment floor: not disclosed
Number of Stock Acquisition Rights
Total issued: 18,100; exercised between 17 March 2026 and 26 March 2026: 8,300; currently unexercised: 9,800
Most recent equity financing
Timing 16 March 2026 / Type Issuance of the 17th Series of Stock Acquisition Rights (with exercise price adjustment provisions) / Amount Not disclosed
| Item | Details |
|---|---|
| Type of issuance or disposal | Exercise of stock acquisition rights with an exercise price adjustment clause |
| Number of shares to be issued or disposed of | 830,000 new shares; 0 treasury shares transferred |
| Dilution Rate | Equivalent to 10.00% of the 8,300,000 issued shares (830,000 shares) |
| Total number of issued shares | 8,300,000 shares → Not disclosed |
| Exercise price | ¥394 (26 March 2026). Details of the adjustment clause and the adjustment floor: not disclosed |
| Number of Stock Acquisition Rights | Total issued: 18,100; exercised between 17 March 2026 and 26 March 2026: 8,300; currently unexercised: 9,800 |
| Most recent equity financing | Timing 16 March 2026 / Type Issuance of the 17th Series of Stock Acquisition Rights (with exercise price adjustment provisions) / Amount Not disclosed |
Items this document does not state (21)
Issue price and disposal priceTotal issue valueAmount of funds to be raisedEstimated issuance expensesSpecific use of fundsPayment dateIntended allotteeIntended allottee's holding policyBasis for determining the amount to be paidExercise periodTransfer restriction periodConditions for lifting transfer restrictionsReason for acquisition without considerationCategories and Number of Persons CoveredTotal Stock-Based CompensationUnderwriter / lead underwriterOverallotmentStock Split RatioProcedures under the Corporate Code of ConductMajor shareholders after the offeringImpact on Business Performance
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.This reports the status of the large-scale exercise; no reason for the exercise is provided.
How to read this page
This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.